NEW
Stock Screener with Intrinsic Value
Royalty Pharma plc (RPRX)
Last Price$30.8(0.6%)
Market Cap$13.8B
$2,265.9M
-2.5% YoY
$1,145.1M
+3,676.1% YoY
$6,608.8M
Net Debt to FCF - 3.7x
$1,801.5M
79.5% margin
RPRX Income Statement
RPRX Income Statement Overview
Crunching data... Almost there!
RPRX Income statement key metrics
Crunching data... Almost there!
RPRX Balance Sheet
RPRX Balance Sheet Overview
Crunching data... Almost there!
RPRX Balance Sheet Metrics
Crunching data... Almost there!
RPRX Cash Flow Statement
RPRX Cash Flow Statement Overview
Crunching data... Almost there!
RPRX Cash Flow Statement key metrics
Crunching data... Almost there!
RPRX Financials
Crunching data... Almost there!
FAQ
What is the Royalty Pharma plc (RPRX) revenue?
The Royalty Pharma plc (RPRX) revenue is $2,354.6M, reflecting a year-over-year (YoY) growth of +5.2% YoY.
What is the Royalty Pharma plc (RPRX) Net Income?
The Royalty Pharma plc (RPRX) Net Income is $1,134.8M, showcasing a YoY growth of +2,549.5% YoY.
What is Royalty Pharma plc (RPRX) net debt?
What is the Royalty Pharma plc (RPRX) Free Cash Flow (FCF)?
The Royalty Pharma plc (RPRX) Free Cash Flow (FCF) stands at $2,987.8M, accounting for a 126.9% margin.